| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.06 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.06 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.089 | 0.07 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.077 | 0.07 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |